中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
28期
159-160
,共2页
慢性乙型肝炎%替比夫定%拉米夫定%临床效果
慢性乙型肝炎%替比伕定%拉米伕定%臨床效果
만성을형간염%체비부정%랍미부정%림상효과
Chronic hepatitis B%Telbivudine%Lamivudine%Clinical effect
目的:比较替比夫定与拉米夫定治疗慢性乙型肝炎的临床效果。方法将我院2012年8月~2015年8月收治的87例慢性乙型肝炎患者分为2组,观察组44例给予替比夫定治疗,对照组43例给予拉米夫定治疗,比较2组的临床效果。结果观察组总有效率为95.45%,不良反应发生率为9.09%,对照组总有效率为72.09%,不良反应发生率为11.63%,2组总有效率差异有统计学意义(P<0.05),不良反应发生率差异无统计学意义(P>0.05)。结论替比夫定治疗慢性乙型肝炎的临床效果优于拉米夫定,其临床疗效较高,不良反应少。
目的:比較替比伕定與拉米伕定治療慢性乙型肝炎的臨床效果。方法將我院2012年8月~2015年8月收治的87例慢性乙型肝炎患者分為2組,觀察組44例給予替比伕定治療,對照組43例給予拉米伕定治療,比較2組的臨床效果。結果觀察組總有效率為95.45%,不良反應髮生率為9.09%,對照組總有效率為72.09%,不良反應髮生率為11.63%,2組總有效率差異有統計學意義(P<0.05),不良反應髮生率差異無統計學意義(P>0.05)。結論替比伕定治療慢性乙型肝炎的臨床效果優于拉米伕定,其臨床療效較高,不良反應少。
목적:비교체비부정여랍미부정치료만성을형간염적림상효과。방법장아원2012년8월~2015년8월수치적87례만성을형간염환자분위2조,관찰조44례급여체비부정치료,대조조43례급여랍미부정치료,비교2조적림상효과。결과관찰조총유효솔위95.45%,불량반응발생솔위9.09%,대조조총유효솔위72.09%,불량반응발생솔위11.63%,2조총유효솔차이유통계학의의(P<0.05),불량반응발생솔차이무통계학의의(P>0.05)。결론체비부정치료만성을형간염적림상효과우우랍미부정,기림상료효교고,불량반응소。
Objective To compare telbivudine with lamivudine in the treatment of chronic hepatitis B clinical results.MethodsThe hospital in August 2012 to August 2015 were treated 87 cases of chronic hepatitis B patients were divided into two groups, the observation group 44 cases given telbivudine treatment, the control group of 43 patients received lamivudine comparison of the clinical effect of the two groups.Results The total effective rate was 95.45%, 9.09% incidence of adverse reactions, the control group, the total effective rate was 72.09%, 11.63% incidence of adverse reactions, there are two groups were statistically significant differences in overall efifciency (P<0.05), incidence of adverse reactions was no signiifcant difference (P>0.05).Conclusion Telbivudine treatment of chronic hepatitis B clinical effect than lamivudine, higher clinical efifcacy and less adverse reactions.